Clinical Trial Update: Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of a buprenorphine transdermal patch for osteoarthritis pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Buprenorphine transdermal patch (buprenorphine)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED